NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

JRROBYN,

I believe that once they have/had the article presented that yes, it is or has been in the process of being expedited. Who knows how long the sign off by doctors might have taken or how long the IDH status has taken. The greatest risk here since 2015 has always been time. With NWBO finding ways to hold off on financing and authorized share increase I have to believe they are getting close in spite of all the obstacles. I believe manufacturing is the key value driver going forward once TLD and a journal article establishes positive data which is just one step in the process towards a BLA or MAA. I believe NWBO has had the outline in place for these for quite some time. The journal article provides a synopsis of part of the overall BLA which also can include manufacturing plans or changes with equivalencies and proof of progress towards commercialization capability which, as flipper44 and others have pointed out, is important for any treatment headed towards SOC. Bottom line is that I do not believe that the journal article publication date significantly changes the BLA/MAA dates. Being prepared for demand for L and a rapid move forward with Direct is way more important to share price with strong data announced, reviewed and supported. This whole process is what gets past any attempts to cast aspersions on data or methods used to validate it and moves the treatments more quickly to patients through commercialization which is what Drs Liau and Ashkan as well as others want ASAP. Best wishes.